Table 2: Some marketed or in clinical trials of nano-preparations.

Name of drug

Active ingredient

Dosage form route of administration

Year of Listing

Marketing status

Company

Remarks

Doxil®

Adriamycin

Injection; Intravenous injection

1995

RX

Sequus pharmaceuticals

RLD

Rapamune®

Sirolimus

Tablet; Oral

2000

RX

PF prism CV

RLD

Emend®

Aprepitant

Capsule; Oral

2003

RX

Merck

RLD

Tricor®

Fenofibrate

Tablet; Oral

2004

RX

Abbvie

RLD

Triglide®

Fenofibrate

Tablet; Oral

2005

RX

Skyepharma AG

RLD

Megace ES®

Megestrol

Suspension; Oral

2005

RX

Endopharms inc

RLD

Liporaxel®

paclitaxel

Solution; Oral

2016

RX

Haihe Biopharma

Listed in Korea

Rybelsus®

Semaglutide

Tablet; Oral

2019

RX

Novo

RLD